Trials / Completed
CompletedNCT03644108
Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers
A Phase I, Open-label, Single-dose, Single-Period Study to Evaluate the Pharmacokinetics of Mucinex® 600 mg Extended-Release Bi-layer Tablet in Normal Healthy Subjects.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Reckitt Benckiser Inc. · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Evaluate the Pharmacokinetics of Mucinex® 600 mg Extended-Release Bi-Layer Tablet in Normal Healthy Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mucinex® ER 600 mg | Single dose of Mucinex® 600 mg ER Bi-Layer tablet |
Timeline
- Start date
- 2009-06-04
- Primary completion
- 2009-06-15
- Completion
- 2009-06-15
- First posted
- 2018-08-23
- Last updated
- 2019-02-28
- Results posted
- 2019-02-28
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03644108. Inclusion in this directory is not an endorsement.